Leimgruber A
Service d'immunologie et d'allergie CHUV, 1011 Lausanne.
Rev Med Suisse. 2006 Jan 11;2(48):89-92.
Allergic rhinitis is a frequent illness. New therapeutic options are being developed to counteract its impact on quality of life and health costs. This article presents two of these options, laser rhinophototherapy and Butterbur Ze 339, a drug derived from petasites. The immunodepressing effect of phototherapy has been tested in nasal mucosa. This application has shown satisfactory anti-inflammatory results in nasal cleaning fluid and, consequently, has enabled to reduce allergic rhinitis. The effect of butterbur on the symptoms of allergic rhinitis has to be understood in relation with the inhibition of cysleucotrienes synthesis, as well as its action on eosinophils and mastocytes. However, long-term studies involving large cohorts of patients are needed if we want to prescribe these treatments without restrictions.
过敏性鼻炎是一种常见疾病。正在研发新的治疗方法以应对其对生活质量和医疗成本的影响。本文介绍其中两种方法,即激光鼻腔光疗和从蜂斗菜中提取的药物Butterbur Ze 339。光疗的免疫抑制作用已在鼻黏膜中进行了测试。这种应用在鼻腔清洗液中显示出了令人满意的抗炎效果,因此能够减轻过敏性鼻炎。必须结合对白三烯合成的抑制作用以及对嗜酸性粒细胞和肥大细胞的作用来理解蜂斗菜对过敏性鼻炎症状的影响。然而,如果我们想毫无限制地开具这些治疗方法,就需要进行涉及大量患者队列的长期研究。